What is Dabrico?
Dabrico specializes in the development and manufacturing of advanced visual inspection machines tailored for the pharmaceutical industry. Leveraging AI and intelligent automation, the company enhances defect detection processes for injectable products. Their comprehensive product line includes automated, semi-automated, and manual visual inspection systems, alongside syringe stopper insertion and auxiliary equipment. Dabrico's mission is to empower pharmaceutical manufacturers with solutions that significantly improve the accuracy and efficiency of their quality control operations, addressing the intricate challenges of visual inspection in a highly regulated sector.
How much funding has Dabrico raised?
Dabrico has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Dabrico
PPP
Public-Private Partnership
What's next for Dabrico?
With its large-scale late-stage funding context, Dabrico is poised for significant expansion and further technological advancement. This strategic investment will likely fuel the scaling of its manufacturing capabilities, enhance its AI-driven inspection technologies, and broaden its market reach within the global pharmaceutical sector. The company's focus on innovation and compliance suggests a trajectory aimed at solidifying its leadership in automated visual inspection solutions, potentially exploring new applications or expanding its service offerings to meet evolving industry demands.
See full Dabrico company page
